Aqualung

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Windward Bio

The company develops long-acting monoclonal antibodies for patients with serious respiratory and dermatological diseases, including severe asthma, chronic obstructive pulmonary disease and atopic dermatitis.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Peroxitech Therapeutics

Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.